141 related articles for article (PubMed ID: 9801431)
1. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery.
Miyazaki S; Suisha F; Kawasaki N; Shirakawa M; Yamatoya K; Attwood D
J Control Release; 1998 Dec; 56(1-3):75-83. PubMed ID: 9801431
[TBL] [Abstract][Full Text] [Related]
2. Thermally reversible xyloglucan gels as vehicles for oral drug delivery.
Kawasaki N; Ohkura R; Miyazaki S; Uno Y; Sugimoto S; Attwood D
Int J Pharm; 1999 Apr; 181(2):227-34. PubMed ID: 10370218
[TBL] [Abstract][Full Text] [Related]
3. Thermally reversible xyloglucan gels as vehicles for nasal drug delivery.
Mahajan HS; Tyagi V; Lohiya G; Nerkar P
Drug Deliv; 2012; 19(5):270-6. PubMed ID: 22823894
[TBL] [Abstract][Full Text] [Related]
4. Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits.
Miyazaki S; Kawasaki N; Endo K; Attwood D
J Pharm Pharmacol; 2001 Sep; 53(9):1185-91. PubMed ID: 11578100
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous absorption of non-steroidal anti-inflammatory drugs from in situ gelling xyloglucan formulations in rats.
Takahashi A; Suzuki S; Kawasaki N; Kubo W; Miyazaki S; Loebenberg R; Bachynsky J; Attwood D
Int J Pharm; 2002 Oct; 246(1-2):179-86. PubMed ID: 12270620
[TBL] [Abstract][Full Text] [Related]
6. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.
Miyazaki S; Suzuki S; Kawasaki N; Endo K; Takahashi A; Attwood D
Int J Pharm; 2001 Oct; 229(1-2):29-36. PubMed ID: 11604255
[TBL] [Abstract][Full Text] [Related]
7. Oral sustained delivery of paracetamol from in situ gelling xyloglucan formulations.
Miyazaki S; Endo K; Kawasaki N; Kubo W; Watanabe H; Attwood D
Drug Dev Ind Pharm; 2003 Feb; 29(2):113-9. PubMed ID: 12648007
[TBL] [Abstract][Full Text] [Related]
8. Thermally gelling poloxamine Synperonic T908 solution as a vehicle for rectal drug delivery.
Miyazaki S; Oda M; Takada M; Attwood D
Biol Pharm Bull; 1995 Aug; 18(8):1151-3. PubMed ID: 8535415
[TBL] [Abstract][Full Text] [Related]
9. Comparison of in situ gelling formulations for the oral delivery of cimetidine.
Miyazaki S; Kawasaki N; Kubo W; Endo K; Attwood D
Int J Pharm; 2001 Jun; 220(1-2):161-8. PubMed ID: 11376978
[TBL] [Abstract][Full Text] [Related]
10. In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery.
Itoh K; Yahaba M; Takahashi A; Tsuruya R; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
Int J Pharm; 2008 May; 356(1-2):95-101. PubMed ID: 18295417
[TBL] [Abstract][Full Text] [Related]
11. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
[TBL] [Abstract][Full Text] [Related]
12. Investigation on rectal absorption of indomethacin from sustained-release hydrogel suppositories prepared with water-soluble dietary fibers, xanthan gum and locust bean gum.
Watanabe K; Yakou S; Takayama K; Machida Y; Isowa K; Nagai T
Biol Pharm Bull; 1993 Apr; 16(4):391-4. PubMed ID: 8395281
[TBL] [Abstract][Full Text] [Related]
13. Drug release from xyloglucan beads coated with Eudragit for oral drug delivery.
Yoo MK; Choi HK; Kim TH; Choi YJ; Akaike T; Shirakawa M; Cho CS
Arch Pharm Res; 2005 Jun; 28(6):736-42. PubMed ID: 16042085
[TBL] [Abstract][Full Text] [Related]
14. Tolmetin sodium-loaded thermosensitive mucoadhesive liquid suppositories for rectal delivery; strategy to overcome oral delivery drawbacks.
Akl MA; Ismael HR; Abd Allah FI; Kassem AA; Samy AM
Drug Dev Ind Pharm; 2019 Feb; 45(2):252-264. PubMed ID: 30303407
[TBL] [Abstract][Full Text] [Related]
15. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats.
Kim JY; Ku YS
Int J Pharm; 2000 Jan; 194(1):81-9. PubMed ID: 10601687
[TBL] [Abstract][Full Text] [Related]
16. Thermosensitive In Situ Gel Based on Solid Dispersion for Rectal Delivery of Ibuprofen.
Liu Y; Wang X; Liu Y; Di X
AAPS PharmSciTech; 2018 Jan; 19(1):338-347. PubMed ID: 28733828
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of gel formulations for oral sustained delivery to dysphagic patients.
Miyazaki S; Takahashi A; Itoh K; Ishitani M; Dairaku M; Togashi M; Mikami R; Attwood D
Drug Dev Ind Pharm; 2009 Jul; 35(7):780-7. PubMed ID: 19337871
[TBL] [Abstract][Full Text] [Related]
18. Study on absorption of indomethacin from sustained-release suppositories containing hydrogenated soybean lecithin in rabbits.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3145-7. PubMed ID: 2632063
[TBL] [Abstract][Full Text] [Related]
19. Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro.
Kanke M; Tanabe E; Katayama H; Koda Y; Yoshitomi H
Biol Pharm Bull; 1995 Aug; 18(8):1154-8. PubMed ID: 8535416
[TBL] [Abstract][Full Text] [Related]
20. Measurement of oligosaccharides derived from tamarind xyloglucan by competitive ELISA assay.
Sone Y; Sato K
Biosci Biotechnol Biochem; 1994 Dec; 58(12):2295-6. PubMed ID: 7765725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
